It claimed 'GLP-1s for diabetes could be sold at a profit for just US $0.89 per month, compared to the price of $95 per month charged in Brazil, $115 per month charged in South Africa, $230 charged in Latvia and $353 charged in the US, which is a 39,562% markup over what the estimated generic price could be.' Christa Cepuch, Pharmacist Coordinator at MSF's Access Campaign, argues 'These new drugs are an absolute game changer for people living with diabetes, but are being kept out of the hands of hundreds of millions of people in low- and middle-income countries who need them' (Barber, Gotham, Bygrave
One of the biggest changes is reduced appetite
Nikolaidis LA, Elahi D, Hentosz T, et al
Why Compounded GLP-1 Timing Differs From Natural Release PlexusDx compounded semaglutide injection provides stable, continuous GLP-1 activity rather than the pulsatile pattern of natural hormone release
Shop now Explore Everlywell
They told us what they want patients to know about how these drugs work, who will benefit from them and what the science says about their long-term use